Oxytocin during late labor to study childbirth changes
Part of Women’s health & pregnancy clinical trials.
This study looks at how oxytocin, a medication that helps labor contractions, affects the second stage of labor. It may help researchers understand what leads to safer and smoother delivery for first-time mothers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant for the first time (no prior births).
- You are at least 37 weeks pregnant.
- Your pregnancy has only one baby.
- You are admitted for labor—either spontaneous labor or labor induction.
- At the time your cervix is fully dilated, you are taking oxytocin as the study needs.
- There is no major baby birth defect, and your medical condition allows a longer second stage if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at when oxytocin is started during the pushing phase of labor to understand if timing affects outcomes for the mother and baby.
This trial tests oxytocin, a drug used to start or strengthen labor, in women who have given birth before and are being induced with a full-term, single baby. It aims to find the best way to use oxytocin safely and effectively.
This study looks at how oxytocin (a labor-inducing/strengthening medicine) may affect your baby’s heart rate during labor. It also compares what happens when labor pain relief is given as a spinal/epidural injection.
This study looks at how oxytocin (a medicine often used to help with labor and uterine contractions) moves through the body and what it does during a non-emergency C-section. It may help improve how oxytocin is used in the future for safer, more predictable delivery care.
This trial tests whether taking a break from oxytocin (a medicine used to strengthen contractions) can help reduce the chance of needing a C-section. It is for women whose labor has slowed down despite oxytocin.
This trial tests whether a continuous oxytocin infusion during a C-section helps maintain labor progress in people already receiving oxytocin. It may help reduce labor-related complications, but only if you meet the safety requirements for anesthesia and pregnancy conditions.
Hear when a new Labor Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.